Report Summary

The global regenerative medicine market size was valued at USD 14.76 billion in 2017 and is anticipated to grow at a CAGR of 20.5% during the forecast period. Regenerative Medicine are defined as the medicines that have that are capable of restoring functionality of the affected cells in the human body. The regenerative medicine is the type of traditional research in tissue engineering. This medicine promises the growth of damaged body organs. These medicines are generally grown in the laboratories and then implanted in the human body that can heal the damaged part themselves. Stem cells are majorly used in treating various diseases and are the most common type of regenerative medicine, for treating various chronic diseases.

The market is primarily driven by the rising prevalence of chronic diseases globally such as cancer, and diabetes. For instance, according to National Cancer Institute in 2018, approximately 1,735,350 new cases of cancer will be diagnosed in the United States and 609,640 people will die from the disease. Furthermore, the increasing awareness for the use of regenerative medicines for treating various life threating diseases to support the market growth in the coming years.



Know more about this report: request for sample pages

Additionally, rising number of geriatric populations globally, increasing research and development in this field, and continuous government efforts that support this research with the increasing funding to boost the regenerative medicine market during the forecast period. However, high cost of treatment by using these medicines, and lack of awareness for this medication would impede the market growth during the forecast period.

Segment Analysis

The global Regenerative Medicine market is segmented on the basis of treatment type, product, application and geography. Based on the therapy type the market is segmented as Tissue engineering, Cell Therapy, Immunotherapy, Gene Therapy. Cell therapy is expected to witness the largest growth owning to the increasing research and development by the biopharmaceutical companies and various private organizations.

On the basis of product type, the market is segmented as Acellular Products, Cellular Products. The cellular products to dominate the entire market during the forecast period. The segments growth is majorly attributed to the increasing awareness for the use of stem cells therapies, and increasing funding on the research for developing stem cells as an effective treatment for various diseases.

The application of regenerative medicine includes Oncology, Dermatology, Orthopedic, Cardiology, CNS Disease, Diabetes, and Others. Oncology to be the largest growing application of regenerative medicines during the forecast period. The growth of this application is majorly driven by the increasing number of patients suffering from various types of cancer, and increased awareness for the use of regenerative medicine as an effective treatment of cancer across the globe.

Regenerative Medicine Market Scope

By Therapy Type By Product Type By Application Type By Region Tissue engineering

Cell Therapy

Immunotherapy

Gene Therapy Acellular Products

Cellular Products

Autologous Products

Allogeneic Products Oncology

Dermatology

Orthopedic

Cardiology

CNS Disease

Diabetes North America (U.S, Canada)

Europe (Germany, UK, France, Italy, Spain, Belgium, Russia, Netherlands, Rest of Europe)

Asia Pacific (China, India, Japan, Korea, Singapore, Malaysia, Indonesia, Thailand, Philippines)

Latin America (Brazil, Mexico, Argentina, Rest of LATAM)

Middle East & Africa (UAE, Saudi Arabia, South Africa, Rest of MEA)

Know more about this report: request for sample pages

Regional Analysis

Geographically, the Regenerative Medicine market is segmented across North America, Europe, Asia Pacific, Latin America, and Middle east & Africa. The North America is the dominating region in this market. The major factors promoting this market growth in this region are rising awareness for the use of these medicines to treat various diseases, and increasing funding line for developing the product line by the private and government organizations. While, Asia Pacific is considered to grow at a faster rate during the forecast the period owning to the increase focus on research and development on regenerative medicine, and various government initiatives to treat various diseases with the help of regenerative medicines.

Competitive Landscape

The major players operating in Regenerative Medicine market include Organogenesis Inc., Vericel Corporation, Osiris Therapeutics, Inc., Stryker Corporation, and NuVasive, Inc., Medtronic Plc., Acelity, Cook Biotech Inc., Integra LifeSciences, C.R. Bard among others. These leading players in this market are introducing innovative products in the market to cater to the consumers. Global players are entering new markets in developing regions to expand their customer base and strengthen market presence